当前位置:首页 > 文献互助 > 互助详情

Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study复制

乔垣结衣 7小时前 21 30 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2025-07-03 09:39:11 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1200/JCO-24-02495复制

文献链接: https://ascopubs.org/doi/10.1200/JCO-24-02495复制

其他信息:

出版社: American Society of Clinical Oncology (ASCO)
作者: Lingfang Xia; Keqiang Zhang; Ying Tang; Guonan Zhang; Danbo Wang; Hanmei Lou; Naifu Liu; Hongping Zhang; Hongwei Chen; Ke Wang; Shuqing Wei; Li Wang; Kun Gao; Guiling Li; Huifeng Zhang; Yuanjing Hu; Weidong Zhao; Yunyan Zhang; Hong Zhu; An Lin; Jinwei Miao; Guohua Yu; Keqin Hua; Liangdan Tang; Ziling Liu; Bingzhong Zhang; Hongwei Li; Min Zheng; Xiaohong Wang; Fenghu Li; Xinfeng Yang; Huaijun Zhou; Bairong Xia; Xianfeng Zhou; Yuting Wang; Quanren Wang; Xiaohua Wu

互助时间线

2025-06-26 09:39:56 [完结求助]

楼主确认了小小奇迹3应助的文件是正确的, 求助状态变成 已完结

2025-06-26 09:39:11 [上传文件]

小小奇迹3上传了文件(pdf 705.09 KB), 求助状态变成 待确认

2025-06-26 09:25:01 [发起求助]